CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,357,215 | -51.3% | 1,052,105 | -35.1% | 0.01% | -50.0% |
| Q2 2023 | $2,788,823 | -2.4% | 1,621,409 | -14.3% | 0.02% | -11.1% |
| Q1 2023 | $2,855,993 | +169.7% | 1,891,386 | +185.8% | 0.02% | +157.1% |
| Q4 2022 | $1,059,028 | -33.3% | 661,892 | -39.5% | 0.01% | -46.2% |
| Q3 2022 | $1,587,000 | -3.3% | 1,094,318 | +22.1% | 0.01% | 0.0% |
| Q2 2022 | $1,641,000 | -42.8% | 896,449 | -16.6% | 0.01% | -31.6% |
| Q1 2022 | $2,871,000 | -46.5% | 1,075,110 | -13.2% | 0.02% | -47.2% |
| Q4 2021 | $5,364,000 | -24.4% | 1,238,911 | -11.1% | 0.04% | -25.0% |
| Q3 2021 | $7,096,000 | -20.7% | 1,394,070 | -1.4% | 0.05% | -21.3% |
| Q2 2021 | $8,950,000 | +93.8% | 1,413,867 | +136.7% | 0.06% | +69.4% |
| Q1 2021 | $4,618,000 | +16.7% | 597,398 | -1.1% | 0.04% | +2.9% |
| Q4 2020 | $3,958,000 | -3.2% | 604,220 | -1.7% | 0.04% | -16.7% |
| Q3 2020 | $4,088,000 | +15.9% | 614,722 | +45.1% | 0.04% | +10.5% |
| Q2 2020 | $3,528,000 | +89.3% | 423,542 | +74.3% | 0.04% | +58.3% |
| Q1 2020 | $1,864,000 | +1.5% | 243,012 | +9.9% | 0.02% | +33.3% |
| Q4 2019 | $1,837,000 | +197.7% | 221,059 | +164.3% | 0.02% | +125.0% |
| Q3 2019 | $617,000 | -24.8% | 83,651 | +14.4% | 0.01% | -27.3% |
| Q2 2019 | $821,000 | +7.9% | 73,151 | +3.3% | 0.01% | 0.0% |
| Q1 2019 | $761,000 | +60.9% | 70,801 | +126.2% | 0.01% | +37.5% |
| Q4 2018 | $473,000 | -18.3% | 31,301 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $579,000 | -26.3% | 31,301 | -9.0% | 0.01% | -33.3% |
| Q2 2018 | $786,000 | +17.1% | 34,381 | +45.7% | 0.01% | +9.1% |
| Q1 2018 | $671,000 | +0.3% | 23,601 | -25.6% | 0.01% | -8.3% |
| Q4 2017 | $669,000 | +200.0% | 31,701 | +158.8% | 0.01% | +200.0% |
| Q3 2017 | $223,000 | – | 12,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |